5AM Venture Management’s Centessa Pharmaceuticals CNTA Stock Holding History

5AM Venture Management’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-580,945	Closed	-$23.1M	–	17
2026 Q1	$23.1M	Hold	580,945	–	–	6.41%	5
2025 Q4	$14.5M	Sell	580,945 -100,000	-15%	-$2.53M	4.57%	9
2025 Q3	$16.5M	Sell	680,945 -150,000	-18%	-$2.67M	6.05%	5
2025 Q2	$10.9M	Hold	830,945	–	–	4.2%	7
2025 Q1	$11.9M	Hold	830,945	–	–	4.52%	6
2024 Q4	$13.9M	Sell	830,945 -454,055	-35%	-$7.52M	3.32%	12
2024 Q3	$20.5M	Buy	1,285,000 +40,000	+3%	+$490K	4.25%	8
2024 Q2	$11.2M	Hold	1,245,000	–	–	2.51%	13
2024 Q1	$14.1M	Buy	+1,245,000	New	+$11.8M	3.15%	14

5AM Venture Management's CNTA Position: Q2 2026 in Review

5AM Venture Management sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 580,945 shares — an estimated $23.1M sold.

5AM Venture Management first reported a position in CNTA in Q1 2024 and held it in 9 quarters. The position peaked at $23.1M in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

5AM Venture Management reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
5AM Venture Management sold 580,945 Centessa Pharmaceuticals shares in Q2 2026, an estimated $23.1M.
5AM Venture Management first reported a position in Centessa Pharmaceuticals in Q1 2024 and held it in 9 quarters.
5AM Venture Management's Centessa Pharmaceuticals position peaked at $23.1M in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on 5AM Venture Management's 13F filing for Q2 2026, filed 14 Aug 2026.